Lymphoma Diagnosis and Treatment

Lymphoma encompasses a broad family of cancers arising from lymphocytes, and distinguishing its many subtypes—from Hodgkin's lymphoma to diffuse large B-cell lymphoma to rarer T-cell malignancies—depends on increasingly precise molecular and genetic classification rather than microscopic appearance alone. Understanding how disruptions in B-cell receptor signaling and specific chromosomal alterations drive malignant transformation has reshaped both how pathologists categorize these diseases and how clinicians select therapies, with targeted agents like rituximab now central to treatment protocols. PET imaging and gene expression profiling have improved the ability to predict which patients will respond to standard regimens and which require more aggressive intervention, though accurately forecasting relapse and resistance in individual patients remains an unresolved challenge. Active research continues to refine the genetic taxonomy of lymphoid neoplasms and to identify new molecular vulnerabilities that could expand treatment options beyond current frontline approaches.

Works

134,989

Total citations

2,014,806

Keywords

LymphomaClassificationMolecular ProfilingRituximabGenetic PathogenesisPET Imaging